| Scar Away Your Pain? Some Docs Back Prolotherapy
In college Barry Taft could bench-press a maximum of 225 pounds. But over time the strain of weight lifting led Taft to severely injure the rotator cuff in his left shoulder. "Boy, it just really hurt after that," Taft said. "For weeks and weeks it would not get any better." Taft could no longer take the 45-pound bar off the rack, let alone bench-press it with weights attached. Eventually he opted for a little-known treatment that involved four sets of injections over the course of a year. .
US consumer sales growth slumps
Consumer spending slowed sharply in the US, official figures showed yesterday, as the country's most powerful consumer products groups warned that a slowdown would crimp profits in the coming months. Procter & Gamble – makers of a raft of household name brands, including Gillette, Ariel and Pringles – said it was already seeing a "modest" deceleration in the US and was finding most of its growth overseas. The federal government's commerce department reported that consumer spending was up just 0.2 per cent in December, an abrupt decline from the 1 per cent rate of growth the previous month. It was the worst reading in six months and took growth for last year as a whole to 5.5 per cent, the slowest year since 2003. The data was accompanied by news of a steeper-than-forecast rise in unemployment claims last week, which may presage even more pressure on spending.
VLCC boosts regional roll-out plan set to open 35 centres in 24 months
Dubai, February 16, 2008: Driven by the buoyant market trends in the wellness domain, VLCC - the region's premier preventive healthcare and beauty care brand - announced plans to increase the number of centres in Middle East to 35 by 2010 compared to the originally-planned 28. The company has committed over AED 200 million to fund the expansion in the region. An announcement to this effect was made at the inauguration of VLCC's seventh centre in the UAE. The new centre, at Al Qusais in Dubai, was inaugurated by His Excellency Sheikh Mohammed Bin Juma Al Maktoum. Also present on the occasion were Indian Consul General, Venu Rajamony, Ms. Vandana Luthra, Founder & Mentor, VLCC, Mr. Mukesh Luthra, Chairman & Managing Director, VLCC Group and special invitees. Speaking on the occasion, Ms.
Campbell's Lowering Sodium in Kids Soups
MOUNT LAUREL, N.J. - The Campbell Soup Co.'s kid-oriented soups, which feature characters such as Dora the Explorer and Batman on the cans, are getting their second sodium reduction in three years, the company announced Monday.
This time, the 12 soups for kids will have 480 milligrams per serving, which means the company can legally label them as healthy foods for the first time.
"Your kids can enjoy Dora the Explorer even more," said Douglas R. Conant, Campbell's president and chief executive, said in an interview. "They'll be down to heart-healthy levels."
.
Sudan Promotes Darfur Atrocities Suspect
The suspected head of a Sudanese militia accused of murder, rape and other atrocities in Darfur has received a senior government post, the Sudanese government confirmed Monday. President Omar al-Bashir dismissed allegations against the man as untrue. Musa Hilal, the alleged leader of the so-called janjaweed militias, was named adviser to Sudan's Ministry of Federal Affairs last week, Sudanese media reported Monday. The ministry manages the central government's relations with the outlying provinces in Africa's largest country. .
MannKind to Present at the Merrill Lynch Global Pharmaceutical ...
VALENCIA, Calif., Feb. 1 /PRNewswire-FirstCall/ -- MannKind Corporation (NASDAQ: MNKD) , focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 6, 2008 at 1:40 PM ET at the Grand Hyatt Hotel in New York, NY. Interested parties can access a link to the live web cast of the presentation in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of the presentation will be available for 14 days. About MannKind Corporation MannKind Corporation (NASDAQ: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.
|
